查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1775454

管瓶市场：2025 年至 2030 年预测

Vials Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计管瓶市场规模将从 2025 年的 120.58 亿美元成长至 2030 年的 159.15 亿美元，复合年增长率为 5.71%。

生物技术进步与投资

生物技术仍是管瓶市场的基石，其应用领域涵盖製药、农业和分子美食。大量投资正在推动该领域的研发，推动了对作为实验室必需部件的管瓶的需求。例如，2024年，ARCH Venture Partners 拨出大量资金支持生物技术创新，支持了 Vir Biotechnology、Alnylam Pharmaceuticals、VBI Vaccines、Brii Biosciences 和 Sana Biotechnology 等专注于先进疗法（包括 COVID-19 治疗）的公司。 Quantalix 正在开发临床检测技术，而 Twist Biosciences 正在开发用于治疗和疫苗开发的基因编辑工具。 Bellerophon 的吸入式一氧化氮输送系统于 2023 年获得美国食品药物管理局 (FDA) 的紧急使用核准，可缓解 COVID-19 患者的呼吸窘迫。 Conagen 致力于永续绿色化学品的合成生物学研发工作，进一步体现了对环保解决方案的追求。在解决全球健康和环境问题的需要的推动下，这些投资预计将增加对管瓶的需求，小瓶对于在研发和生产过程中储存和处理敏感生物材料至关重要。

政府支持政策

政府的优惠政策鼓励生物技术及相关领域的影响力投资和研发，进而促进市场成长。例如，欧盟（EU）的目标是到2025年将GDP的3.5%用于研发支出，以促进创新，如联邦研究与创新资助咨询服务中心所述。在印度，生物技术部（DBT）和印度医学研究理事会（ICMR）制定了“国家干细胞治疗指南”，建议到2024年资助47个合作计划。这些措施正在推动生物技术研究，并增加了实验室对用于样本储存、测试和开发的管瓶的需求。此类政府支持将维持科研必需管瓶的需求，并在预测期内推动市场扩张。

个人护理和营养补充剂的增长

另一个关键驱动因素是个人保健产品和营养补充剂的需求不断增长，尤其是在註重健康的都市区消费者群体中。可支配收入的增加促使消费者偏好高端产品，例如基于植物化学成分的营养补充剂和不含有害化学物质的洁净标示护肤。这一趋势正推动市场参与者扩大其创新健康产品阵容，使得管瓶在产品开发和零售包装中成为必要。例如，管瓶可用于在研发过程中储存活性成分，并作为高端个人保健产品（如精华液和精油）的高端包装。日益增长的城市人口重视健康和永续性，这进一步扩大了这一需求，并推动了管瓶市场的发展。

区域洞察

北美市场占有率，这得益于其在生物技术领域的大量投资、先进的医疗基础设施以及消费者在个人护理和营养补充剂方面的高支出。美国尤其受益于其强大的研发生态系统和对生物技术进步的监管支持。亚太地区是成长最快的市场，这得益于都市化加快、可支配收入增加以及印度和中国等国政府为加强生物技术和医疗保健产业所采取的倡议。欧洲也因其强有力的政策框架支持研发和永续产品开发而成为主要贡献者。

市场挑战

管瓶市场面临与供应链限制和原材料成本相关的挑战，尤其是在生物技术和製药领域所需的高品质玻璃和塑胶管瓶方面。此外，管瓶设计和材料也需要持续创新，以确保其适用于从无菌药物储存到消费者个人保健产品等各种应用。医疗和食品应用中使用的管瓶的合规性也增加了复杂性，并可能增加製造成本。

结论

预计到2028年，管瓶市场将迎来强劲成长，这得益于生物技术的进步、政府的支持政策以及个人护理和营养补充剂需求的不断增长。研发投入，尤其是在北美和亚太地区，正在推动实验室和产品开发对管瓶的需求。消费品朝向高端化和健康化方向的转变，进一步推动了包装应用对管瓶的需求。然而，供应链约束和法规遵从性等挑战需要策略性解决方案来维持市场动能。产业参与者必须专注于技术创新和扩充性，才能抓住这些成长机会。

本报告的主要优点

  • 深刻分析：获得涵盖主要地区和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力进行策略决策并在动态环境中开闢新的业务流和收益。
  • 适合广泛的使用者：对于新兴企业、研究机构、顾问、中小企业和大型企业来说都是有益且具有成本效益的。

它有什么用途？

产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测细分市场和区域分析（包括国家）
  • 公司概况（尤其是财务状况和关键发展）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 研究范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章管瓶市场（依容量）

  • 介绍
  • 最大2毫升
  • 3ml～5ml
  • 5ml～7ml
  • 8毫升或更多

第六章管瓶瓶市场（依材质）

  • 介绍
  • 玻璃
    • 硼硼硅酸玻璃
    • 熔融石英
  • 聚合物
  • 塑胶
    • 热塑性塑料
      • HDPE
      • 聚氯乙烯
      • 聚碳酸酯
      • 聚丙烯
    • 热固性树脂
      • 三聚氰胺甲醛
      • 苯酚甲醛
      • 聚脲甲醛
      • 其他的

第七章管瓶市场：依灌装技术

  • 介绍
  • 净重填料
  • 旋转包装
  • 体积填充剂
  • 其他填充剂

第 8 章管瓶市场（依最终用户）

  • 介绍
  • 个人护理
  • 化学品
  • 卫生保健
  • 医院
  • 製药
  • 研究办公室

第九章管瓶瓶市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 台湾
    • 泰国
    • 其他的

第十章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十一章 公司简介

  • Amcor plc
  • Gerresheimer AG
  • SCHOTT AG
  • West Pharmaceutical Services, Inc.
  • Becton, Dickinson and Company
  • AptarGroup, Inc.
  • Corning Incorporated

第十二章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061613493

The Vials Market is expected to grow from USD 12.058 billion in 2025 to USD 15.915 billion in 2030, at a CAGR of 5.71%.

Biotechnology Advancements and Investments

Biotechnology remains a cornerstone of the vials market, with its applications spanning pharmaceuticals, agriculture, and molecular gastronomy. Significant investments are fueling research and development (R&D) in this sector, increasing the demand for vials as essential laboratory components. For instance, in 2024, ARCH Venture Partners allocated substantial funding to support biotech innovation, backing companies like Vir Biotechnology, Alnylam Pharmaceuticals, VBI Vaccines, Brii Biosciences, and Sana Biotechnology, which focus on advanced therapeutics, including COVID-19 treatments. Quanterix is advancing clinical testing technologies, while Twist Biosciences develops gene-editing tools for therapeutic and vaccine development. Bellerophon's inhaled nitric oxide delivery systems, approved for emergency use by the FDA in 2023, address respiratory distress in COVID-19 patients. Conagen's synthetic biology R&D, aimed at sustainable green chemicals, further exemplifies the push for eco-friendly solutions. These investments, driven by the need to address global health and environmental challenges, are expected to heighten the demand for vials, which are critical for storing and handling sensitive biological materials during R&D and production processes.

Supportive Government Policies

Favorable government policies are catalyzing market growth by promoting impact investments and R&D in biotechnology and related fields. For example, in 2025, the European Union targeted 3.5% of GDP for R&D spending to foster innovation, as outlined by the Federal Funding Advisory Service for Research and Innovation. In India, the Department of Biotechnology (DBT) and the Indian Council of Medical Research (ICMR) are formulating the "National Guidelines for Stem Cell Therapy," with 47 collaborative projects recommended for funding in 2024. These initiatives enhance biotechnological research, increasing the need for vials in laboratories for sample storage, testing, and development. Such government-backed efforts ensure sustained demand for vials as an indispensable component of scientific research, driving market expansion over the forecast period.

Growth in Personal Care and Nutraceuticals

The rising demand for personal care products and nutraceuticals, particularly among health-conscious urban consumers, is another key driver. Increasing disposable incomes have shifted consumer preferences toward premium and luxury products, including phytochemical-based nutraceuticals and clean-label skincare free of harmful chemicals. This trend has prompted market players to expand their product portfolios to include innovative, health-focused offerings, necessitating vials for both product development and retail packaging. For instance, vials are used to store active ingredients during R&D and as premium packaging for high-end personal care products, such as serums and essential oils. The growing urban population's focus on wellness and sustainability further amplifies this demand, propelling the vials market.

Regional Insights

North America holds a significant market share, driven by substantial biotech investments, advanced healthcare infrastructure, and high consumer spending on personal care and nutraceuticals. The United States, in particular, benefits from robust R&D ecosystems and regulatory support for biotechnological advancements. The Asia-Pacific region is the fastest-growing market, fueled by increasing urbanization, rising disposable incomes, and government initiatives in countries like India and China to bolster biotech and healthcare sectors. Europe also contributes significantly, with strong policy frameworks supporting R&D and sustainable product development.

Market Challenges

The vials market faces challenges related to supply chain constraints and raw material costs, particularly for high-quality glass and plastic vials required in biotechnology and pharmaceuticals. Additionally, ensuring compatibility with diverse applications, from sterile pharmaceutical storage to consumer-facing personal care products, requires ongoing innovation in vial design and materials. Regulatory compliance for vials used in medical and food applications also adds complexity, potentially increasing production costs.

Conclusion

The vials market is set for robust growth through 2028, driven by biotechnology advancements, supportive government policies, and rising demand for personal care and nutraceutical products. Investments in R&D, particularly in North America and Asia-Pacific, are increasing the need for vials in laboratories and product development. The shift toward premium, health-focused consumer goods further boosts demand for vials in packaging applications. However, challenges like supply chain constraints and regulatory compliance require strategic solutions to sustain market momentum. Industry players must focus on innovation and scalability to capitalize on these growth opportunities.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Capacity

  • Up to 2 ml
  • 3 ml - 5 ml
  • 5 ml - 7 ml
  • 8 ml and above

By Material

  • Glass
  • Borosilicate glass
  • Fused Silica
  • Polymer
  • Plastic
  • Thermoplastics
  • HDPE
  • Poly Vinyl Chloride
  • Polycarbonate
  • Polypropylene
  • Thermosets
  • Melamine Formaldehyde
  • Phenol Formaldehyde
  • PolyUrea Formaldehyde
  • Others

By Filling Technology

  • Net weight fillers
  • Rotary fillers
  • Volumetric fillers
  • Other fillers

By End User

  • Personal Care
  • Chemicals
  • Healthcare
  • Hospitals
  • Pharmaceuticals
  • Research Laboratories

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. VIALS MARKET BY CAPACITY

  • 5.1. Introduction
  • 5.2. Up to 2 ml
  • 5.3. 3 ml - 5 ml
  • 5.4. 5 ml - 7 ml
  • 5.5. 8 ml and above

6. VIALS MARKET BY MATERIAL

  • 6.1. Introduction
  • 6.2. Glass
    • 6.2.1. Borosilicate glass
    • 6.2.2. Fused Silica
  • 6.3. Polymer
  • 6.4. Plastic
    • 6.5.1. Thermoplastics
      • 6.5.1.1. HDPE
      • 6.5.1.2. Poly Vinyl Chloride
      • 6.5.1.3. Polycarbonate
      • 6.5.1.4. Polypropylene
    • 6.5.2. Thermosets
      • 6.5.2.1. Melamine Formaldehyde
      • 6.5.2.2. Phenol Formaldehyde
      • 6.5.2.3. PolyUrea Formaldehyde
      • 6.5.2.4. Others

7. VIALS MARKET BY FILLING TECHNOLOGY

  • 7.1. Introduction
  • 7.2. Net weight fillers
  • 7.3. Rotary fillers
  • 7.4. Volumetric fillers
  • 7.5. Other fillers

8. VIALS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Personal Care
  • 8.3. Chemicals
  • 8.4. Healthcare
  • 8.5. Hospitals
  • 8.6. Pharmaceuticals
  • 8.7. Research Laboratories

9. VIALS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. Taiwan
    • 9.6.5. Thailand
    • 9.6.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Amcor plc
  • 11.2. Gerresheimer AG
  • 11.3. SCHOTT AG
  • 11.4. West Pharmaceutical Services, Inc.
  • 11.5. Becton, Dickinson and Company
  • 11.6. AptarGroup, Inc.
  • 11.7 Corning Incorporated

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations